Last updated 40 days ago
Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy
464 patients around the world
Available in Spain, Argentina
Chiesi Farmaceutici S.p.A.
19Research sites
464Patients around the world
This study is for people with
Asthma
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
InAER - Investigaciones en Alergia y Enfermedades Respiratorias - CABA, Buenos Aires
Servicio de Investigación de Patologías Alérgicas del Instituto ABC
Instituto Médico Damic S.R.L.
Clínica Mayo de UMCB SRL
Instituto del Buen Aire
Instituto de Especialidades de la Salud Rosario Clínica del Tórax
Instituto Ave Pulmo
Centro de Investigaciones Médicas Mar del Plata SRL
Consultorios Médicos Dr. Isaac Scherbovsky - Mendoza
Instituto INSARES - Mendoza
StudyTANGO
SponsorChiesi Farmaceutici S.p.A.
Conditions
Requirements
To 75 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06029595
